Gilead, Galapagos bag Jyseleca EC approval for rheumatoid arthritis

pharmanewsdaily- September 27, 2020 0

Jyseleca EC approval : Gilead Sciences and Galapagos have secured marketing authorization for Jyseleca (filgotinib 200 mg and 100 mg tablets) from the European Commission ... Read More